CONNECT WITH US
Gaming

Gaming

Remedy Q3 revenue triples to €39.6m following launch of Control Resonant

GamesIndustry.biz logo

Published on

Add as a preferred source on Google
Remedy Q3 revenue triples to €39.6m following launch of Control Resonant

CEO says Resonant's successful launch "marks a defining milestone for the company"

Remedy's third quarter revenue surged by 226% following the September 24 launch of Control Resonant, which CEO Jean-Charles Gaudechon called "a defining milestone for the company."

The game's physical release occurred after the financial review period, on October 15. Since then, Resonant has sold over one million units, making it Remedy's fastest-selling title to date.

Remedy's third quarter revenue tripled, driven by preorders of Resonant and its first seven days of sales.

The US represented nearly half of Resonant's PC and console sales. On PC, Chinese-speaking regions and the UK ranked second and third. On console, the UK, Canada, and Brazil ranked second, third, and fourth, respectively.

Internal data from Remedy indicated that nearly half of Resonant players were new to the Control franchise. "Reaching new players was a key goal for this game, and these early results indicate a growing audience for the franchise and for Remedy," the developer stated.

Remedy noted that the game's outstanding wishlists total 2.4 million, "providing a substantial potential audience for the future."

2019's Control also benefited from Resonant's successful launch, with sales exceeding "both the comparison period and the first two quarters of the year."

Remedy described the Alan Wake franchise as having "a quieter quarter," but noted that Alan Wake 2's capitalised development costs are now fully depreciated.

Game sales and royalties accounted for most of Remedy's Q3 revenue, totaling €35 million, up from €6 million in the same period last year.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.